PORT WASHINGTON, N.Y.--(BUSINESS WIRE)-- Dogs treated with platelet therapy from a unique filter-based process showed significant improvement from osteoarthritis-related pain and lameness according to a new study commissioned by Pall Corporation (NYSE: PLL). Results from the study, a two-center, prospective randomized controlled clinical trial, were revealed last night at the 39thVeterinary Orthopedic Society (VOS) Meeting in Crested Butte, Colorado. "This study is the first to provide evidence in support of platelet therapy for canine osteoarthritis, said Dr. Alicia L. Bertone, DVM, Ph.D, Diplomate of the American College of Veterinary Surgeons (DACVS), Professor and Director of the Comparative Orthopedic Research Laboratory at The Ohio State University, and senior author of the study. The findings were presented by the studys co-author, Dr. Maria Fahie, DVM, DACVS and Professor of Small Animal Surgery at Western University of Health Sciences, College of Veterinary Medicine. Osteoarthritis, a progressive chronic degenerative joint disease characterized by pain and stiffness in the joints, is a major concern for owners of the more than 72 million pet dogs1 in the United States. Approximately one in five adult dogs in the U.S.2 suffers from osteoarthritis. Common canine treatment methods can range from weight control and exercise to the administration of … Continue reading →

SILVER SPRING, Md.--(BUSINESS WIRE)-- Nuvilex, Inc. (OTCQB:NVLX), an emerging biotechnology provider of cell and gene therapy solutions, today discussed the potential use of the companys cell encapsulation technology with modified stem cells to treat late stage cancers. Stem cell therapy is not new to physicians dealing with blood and bone cancers, with stem cell transplants being an important treatment for growing new bone marrow since the 1970s. Recent studies have indicated the potential for using stem cells across a much broader range of cancers is becoming a reality, mostly a result of advances in cell and molecular biology techniques. Traditional chemotherapy works by targeting the fast-growing cells common to cancer tumors. Unfortunately, chemotherapeutics dont differentiate between healthy and cancerous cells. Patients suffering from metastatic cancers, where tumors have spread to multiple areas of the body, often have substantial difficulties with the chemotherapy needed to treat their disease. In one case, researchers at City of Hope and St. Jude Children's Research Hospital may have found a way to treat cancers that have spread throughout the body more effectively. They used genetically modified stem cells to activate chemotherapeutic drugs at the tumor sites, so that normal tissue surrounding the tumor and throughout … Continue reading →

By David Fitzpatrick and Drew Griffin, Special Investigations Unit updated 1:34 PM EST, Thu March 8, 2012 Dr. Zannos Grekos, seen here in 2009, could have his license suspended. STORY HIGHLIGHTS (CNN) -- A Florida cardiologist could have his medical license revoked by state authorities who have accused him of performing illegal stem cell therapy treatment on an elderly patient who died during the procedure. Florida's Department of Health ordered the emergency suspension of Dr. Zannos Grekos' medical license Wednesday, accusing the Bonita Springs doctor of violating an emergency order against using stem cell treatments in Florida and allegedly causing the death of an unnamed elderly patient. Grekos can appeal the order. According to the license suspension order, Grekos performed a stem cell treatment earlier this month on the patient, who was suffering from pulmonary hypertension and pulmonary fibrosis. Both diseases restrict blood flow to the heart. "During said stem cell treatment, patient R.P. suffered a cardiac arrest and died," the suspension order said. CNN first investigated Grekos's activities in 2009 and, at that time, he said he was using stem cell therapy for a company he called Regenocyte Therapeutic. His profile, listed on the company's website, describes Grekos as … Continue reading →